Mutation, variant, strain… 🤔 We explain it to you 💡 cogconsortium.uk/what-do-virolo…

📢 Applications OPEN! Viral #Genomics & #Bioinformatics, in Asia Develop skills in viral genome sequencing & analysis (incl. #SARSCoV2) Build capacity in your region. #GenomicsIsGlobal 📅Apply by 26 May: bit.ly/3CNhtDK

We've been learning a lot about how Omicron BA.1 and BA.2 compare in recent weeks. Here's a summary table that I compiled and will update when more data become available

Delighted that we received news today Public Health Wales that our SARS-CoV-2 sequencing service (covering end to end Oxford Nanopore and Illumina sequencing and bioinformatics) has been awarded ISO 15189 accreditation! Think we may be the first UK Public Health Agency to achieve this!

🎧 Prof Sharon Peacock, Chair of COG-UK, has recently been featured in two podcasts Cambridge University 🎙️ Genomics Unravelled 👇 anchor.fm/genomicsunrave… 🎙️ CSaP - The Centre for Science and Policy 👇 Robert Doubleday youtube.com/watch?v=ayFtoO…

Hmm - surveillance being shut down. Getting our last wastewater runs on - but the final dataset will be delayed due to covid.... who'd have thought it.

✍️“We get surges of interest, like when Omicron emerged, we got a 𝘴𝘱𝘪𝘬𝘦 in hits with many people interested in the latest data updates.” COG-UK Mutation Explorer Derek Wright MRC-Uni of Glasgow Centre for Virus Research CVR Bioinformatics cogconsortium.uk/exploring-muta…

How can global collaboration 🤝 and genomics training 🧬 better prepare us to tackle COVID-19 variants and future pandemics? 🦠 Hear from Prof Peacock in our next event: 📅 5th April ⏰ 18:30-19:30 BST 💻 Online Cambridge Infectious Diseases IRC #CamFest ⬇️ Register cogconsortium.uk/cam-fest-conve…

✍️ “We cannot just assume that the next virus is going to behave like Omicron, we’ve got to be aware that there is the possibility for future waves to be more dangerous. We have to be prepared.” Emma Thomson @iiiglasgow MRC-Uni of Glasgow Centre for Virus Research cogconsortium.uk/it-was-unlike-…

Follow us on sars2.cvr.gla.ac.uk/cog-uk/ where you can find all SARS-CoV-2 recombinants in the UK. XE is growing!! 🧬

How does Next Generation Sequencing work? 🧬 Watch this live demonstration ⬇️ youtu.be/0iok-W3N_Iw

It was also important for COVID-19 Genomics UK (COG-UK) Consortium to reinforce a culture of collaboration 🤝 and data sharing 📥 #CamFest Cambridge Infectious Diseases IRC Read more 👇 cogconsortium.uk/unprecedented-…

BA.4 and BA.5 in the UK are still low in numbers. Follow us on sars2.cvr.gla.ac.uk/cog-uk/ COVID-19 Genomics UK (COG-UK) Consortium #genomics #covid

Omicron certainly deserves to be named as a novel 2nd "strain" of SARS-CoV-2; SARS-3 however should be reserved for a putative SARS-CoV-3, ie, another spillover of a SARS-related coronavirus from horseshoe bats. Eric Topol Kristian G. Andersen Tulio de Oliveira Linfa Wang @gretchenvogel

with amalio telenti & Dr Emma Hodcroft we discussed these definitions in our recent review on The Evolution and Biology of SARS-CoV-2 Variants -- perspectivesinmedicine.cshlp.org/cgi/content/lo…

Excited to share one of our latest works on monoclonal Antibodies and COVID-19 variants today published on nature journal. A big thank to @MacGregorCox Tom Peacock Robertson Will Harvey COVID-19 Genomics UK (COG-UK) Consortium #nature #medicine nature.com/articles/s4157…

Monoclonal antibody (mAb) therapies have been one of the most successful and effective treatments against SARS-CoV-2 during the pandemic. However with the emergence of of variants thier effectiveness has gradually diminished with each new wave.

To help navigate this very dense area of the literature we have written an in depth paper (part review, part meta-analysis) summerising the literature on the topic of mAbs and variants. (led by MacGregor Cox, Robertson & Alessandro Carabelli) nature.com/articles/s4157…

Mutation Explorer is unavailable today (Saturday 13th May) due to major electrical works requiring server shutdown. We hope to make Mutation Explorer available on Sunday 14th May if the works have been completed. We apologise for any inconvenience.